sulfisoxazole


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to sulfisoxazole: Sulfamethizole

sulfisoxazole

 [sul″fĭ-sok´sah-zōl]
a short-acting sulfonamide antibacterial; used as the base or as sulfisoxazole acetyl particularly for infections of the urinary tract and as sulfisoxazole diolamine as a topical ophthalmic antibacterial.

sulfisoxazole

Gantrisin® Pharmacology A sulfonamide used primarily to treat UTIs
References in periodicals archive ?
strAB, sul2, dfrA27, tetA * Drugs tested were AMP, ampicillin; AMC, amoxicillin/clavulanic acid; AZM, azithromycin; CHL, chloramphenicol; CIP, ciprofloxacin; CRO, ceftriaxone; FIS, sulfisoxazole; FOX, cefoxitin; GEN, gentamicin; KAN, kanamycin; NAL, nalidixic acid; STR, streptomycin; TET, tetracycline; TIO, ceftiofur; and TMP/SXT, trimethoprim/sulfamethoxazole; S83I, serine-to-isoleucine change at amino acid position 83; S85L, serine-to-leucine change at amino acid position 85.
Amoxicillin is estimated to be prescribed in about 38% of the visits, followed by trimethoprim/sulfamethoxazole (10%), erythromycin/ sulfisoxazole (10%), and cefaclor (9%) and topical polymyxin B/neomycin/hydrocortisone (9%) (NAMCS, data set, 1985, unpublished data).
Initial antimicrobial susceptibility testing performed at LNSP indicated that all isolates were susceptible to tetracycline (a proxy for doxycycline) but resistant to sulfisoxazole and nalidixic acid.
Sulfisoxazole as chemoprophylaxis for recurrent otitis media: A double-blind cross-over study in pediatric practice.
A recent study compared the effectiveness of sulfisoxazole (a sulfa antibiotic) to ear tubes.
Antimicrobial susceptibility screening using a panel of 15 agents (amikacin, amoxicillin/clavulanic acid, ampicillin, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole, tetracycline, and trimethoprim/ sulfamethoxazole) was conducted by the Public Health Agency of Canada, Laboratory for Foodborne Zoonoses.
This type was resistant to sulfatrimethoprim, nalidixic acid, sulfisoxazole, streptomycin, and furazolidone.
[29,65] Sulfisoxazole (100 to 150 mg/kg daily, orally or intravenously, used after 1 month of age) was as effective as erythromycin in one study.
Pure cultures were tested by disk diffusion on Mueller-Hinton agar without blood with amoxicillin/clavulanate, ampicillin, chloramphenicol, ciprofloxacin, furazolidone, nalidixic acid, streptomycin, sulfisoxazole, tetracycline (as a marker for doxycycline), and trimethoprim/ sulfamethoxazole (Becton Dickinson, Franklin Lakes, NJ, USA).
([dagger]) Includes amikacin, amoxicillin-clavulanic acid, ampicillin, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole, tetracycline, and trimethoprim-sulfphamethoxazole.
They showed susceptibility to azithromycin and tetracycline, reduced susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L), and resistance to furazolidone, nalidixic acid, sulfisoxazole, streptomycin, and trimethoprim/ sulfamethoxazole.
All three isolates were resistant to trimethoprim-sulfamethoxazole, sulfisoxazole, streptomycin, and furazolidone.